RT Journal Article
SR Electronic
T1 Metabolic correlates of late midlife cognitive function: findings from the 1946 British Birth Cohort
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.23.20236463
DO 10.1101/2020.11.23.20236463
A1 Green, Rebecca
A1 Lord, Jodie
A1 Xu, Jin
A1 Maddock, Jane
A1 Kim, Min
A1 Dobson, Richard
A1 Legido-Quigley, Cristina
A1 Wong, Andrew
A1 Richards, Marcus
A1 Proitsi, Petroula
YR 2020
UL http://medrxiv.org/content/early/2020/11/27/2020.11.23.20236463.abstract
AB Background Investigating associations between metabolites and late midlife cognitive function could reveal potential markers and mechanistic insights relevant to early dementia. Here, we aimed to identify the metabolic underpinnings of cognitive outcomes in late midlife by exploring and integrating associations of single metabolites, metabolic pathways and networks. We further aimed to untangle the influence of life course factors on these relationships; a previously unexplored avenue using a systems biology approach.Methods and Findings Levels of 1019 metabolites were detected by liquid chromatography-mass spectrometry (Metabolon Inc) and quantified at age 60-64 among participants of the British 1946 Birth Cohort (N=1740). Cognitive outcomes were assessed at the same age and 5-9 years later, and included short-term memory (age 60-64, 69 and change), delayed memory (age 60-64), processing speed (age 60-64, 69 and change) and Addenbrooke’s Cognitive Examination III (age 69). Using a combination of linear regression analysis, quantitative pathway analysis and weighted gene correlation network analysis, we evaluated relationships between metabolite measures (single-metabolites, pathways and network modules) and cognitive outcomes. Single-metabolite and network analyses were sequentially adjusted for life course factors across four models, including: sex and blood clinic information (model 1); model 1 + BMI and lipid medication (model 2); model 2 + childhood cognition, education and socioeconomic position (model 3); model 3 + smoking, exercise, alcohol intake, blood pressure and diet (model 4).After correcting for multiple tests, we identified 155 metabolites, 10 pathways and 5 modules to show relationships with cognitive outcomes. Thirty-five metabolites were influential in their module and identified in single-metabolite analyses. Notably, we report independent relationships between a module comprised of acylcarnitines and processing speed, revealing palmitoylcarnitine (C16) as a key driver of associations (model 4: ß = −0.10, 95%CI = −0.15 to −0.052). Two modules demonstrated associations with several cognitive outcomes that were partly explained by life course factors: one enriched in modified nucleosides and amino acids (ß range (model 1) = −0.12 to −0.09, attenuation (model 4)= 39.2 to 55.5%), and another in vitamin A and C metabolites (ß range (model 1) = 0.11 to 0.23, attenuation (model 4) = 68.6 to 92.6%). Our other findings, including a module enriched in sphingolipid pathways (ß range (model 1) = 0.085 to 0.10, attenuation (model 4) = 87.0 to 116%), were entirely explained by life course factors particularly childhood cognition and education. The limitations of this study include those commonly seen with population-based cohorts, such as possible residual confounding and generalisability to other populations, as well as a lack of longitudinal metabolite data.Conclusions Using a large birth cohort study with information across the life course, we highlighted potential metabolic mechanisms underlying cognitive function in late midlife, suggesting marker candidates and life course relationships for further study.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis paper represents independent research part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. This work was further supported by the UK Medical Research Council which provides core funding for the MRC National Survey of Health and Development.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study obtained ethical approval from Greater Manchester Local Research Ethics Committee and the Scotland Research Ethics committee. Research was conducted in accordance with the Declaration of Helsinki and all participants provided written informed consent at each wave.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are stored and held by the MRC Unit of Lifelong Health & Ageing, UCL. Requests for data can be made by contacting the unit directly.